Kim Kelderman - Nov 19, 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Pres. Diagnostics & Genom
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for KimKelderman pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Nov 19, 2021
Transactions value $
-$177,299
Form type
4
Date filed
11/23/2021, 07:02 PM
Previous filing
Sep 24, 2021
Next filing
Feb 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $75.4K +500 $150.78 500 Nov 19, 2021 Direct
transaction TECH Common Stock Sale -$50.4K -100 -20% $503.76* 400 Nov 19, 2021 Direct
transaction TECH Common Stock Sale -$202K -400 -100% $505.78* 0 Nov 19, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Option (Right to Buy) Options Exercise $0 -500 -18.85% $0.00 2.15K Nov 19, 2021 Common Stock 500 $150.78 Direct F2
holding TECH Stock Option (Right to Buy) 7.35K Nov 19, 2021 Common Stock 7.35K $150.78 Direct F3
holding TECH Stock Option (Right to Buy) 12K Nov 19, 2021 Common Stock 12K $177.32 Direct F4
holding TECH Stock Option (Right to Buy) 9.03K Nov 19, 2021 Common Stock 9.03K $177.32 Direct F5
holding TECH Restricted Stock Units 2.36K Nov 19, 2021 Common Stock 2.36K Direct F6, F7
holding TECH Stock Option (Right to Buy) 12K Nov 19, 2021 Common Stock 12K $190.41 Direct F7
holding TECH Stock Option (Right to Buy) 15.9K Nov 19, 2021 Common Stock 15.9K $190.41 Direct F8
holding TECH Restricted Stock Units 2.02K Nov 19, 2021 Common Stock 2.02K Direct F6, F9
holding TECH Stock Option (Right to Buy) 8.99K Nov 19, 2021 Common Stock 8.99K $267.87 Direct F9
holding TECH Stock Option (Right to Buy) 12K Nov 19, 2021 Common Stock 12K $267.87 Direct F10
holding TECH Stock Option (Right to Buy) 8.33K Nov 19, 2021 Common Stock 8.33K $267.87 Direct F11
holding TECH Stock Option (Right to Buy) 8.33K Nov 19, 2021 Common Stock 8.33K $267.87 Direct F12
holding TECH Restricted Stock Units 1.25K Nov 19, 2021 Common Stock 1.25K Direct F6, F13
holding TECH Stock Option (Right to Buy) 4.86K Nov 19, 2021 Common Stock 4.86K $481.82 Direct F13
holding TECH Stock Option (Right to Buy) 6.49K Nov 19, 2021 Common stock 6.49K $481.82 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $505.62 to $506.17, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Options to purchase 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
F3 Options to purchase 1,837 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
F4 Options to purchase 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022.
F5 Fully exercisable.
F6 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F7 Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
F9 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10 Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F11 Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F12 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F13 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F14 Options to purchase 1,621 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,622 shares vest on each of 8/6/2024 and 8/6/2025.